Recurrent Gastric Cancer Completed Phase 2 Trials for Imatinib (DB00619)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068380A Phase II Trial of STI571 in the Treatment of Metastatic Gastric CancerTreatment